Biopharm Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biopharm corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biopharm Corp Today - Breaking & Trending Today

Pelabresib/Ruxolitinib Combo Improves Splenomegaly, TSS in JAK Inhibitor–Naive Myelofibrosis

Pelabresib plus ruxolitinib demonstrated a 35% or greater reduction in spleen volume and trended toward reducing mean absolute total symptom score (TSS) as well as improving TSS reduction by 50% at 24 weeks in patients with JAK inhibitor–naive myelofibrosis. ....

Zentalis Incyte , Ryvu Incyte , Biopharm Corp , Pharm Corp , Palebresib Plus Ruxolitinib , Jak Inhibitor Naive Myelofibrosis , Manifest 2 Trial , Ash Annual Meeting , Cpi 0610 ,

Intech testing new asthma inhaler with eye on US market

Intech Biopharm Corp (益得生技) has started testing the effects of a metered-dose inhaler generic of Teva Pharmaceutical Industries Ltd’s ProAir, and expects to gain marketing approval by 2023, it said yesterday.
The company, which developed SYN011 to treat acute asthma, received approval from the US Food and Drug Administration in August to study the biochemical and physiological effects of the drug in a phase 3 clinical trial, Intech spokesperson Hugues Hung (洪堯國) told the Taipei Times.
The company has recruited about 200 participants with asthma for the test, dividing them into control and experiment groups to receive a placebo, a brand name ....

T Ai Pei , Teva Proair , Peter Lin , Cipla Ltd , Intech Biopharm Corp , Merck Sharp Dohme Ltd , Taipei Exchange On , Taipei Times , Lupin Ltd , Teva Pharmaceutical Industries Ltd Proair , Kao Shih Ching , Biopharm Corp , Teva Pharmaceutical Industries Ltd , Drug Administration , Hugues Hung , Taipei Exchange , India Based Cipla Ltd , Merck Sharp , Dohme Ltd , The Taipei Times ,